Activist investor Sarissa Takes Aim At Innoviva CEO Compensation

(FINalternatives) Alex Denner’s activist hedge fund Sarissa Capital Management is seeking a sharp reduction in the compensation of Innoviva’s chief executive Michael Aguiar, the latest salvo by the investment manager in its proxy fight against the drug company.

To read this article:

This entry was posted in Syndicated. Bookmark the permalink.

Leave a Reply